Evidence map›Paper›PMID 38731142›Full record

ArticleJournal of clinical medicine2024

Does FDG PET-Based Radiomics Have an Added Value for Prediction of Overall Survival in Non-Small Cell Lung Cancer?

Andrea Ciarmiello, Elisabetta Giovannini, Francesca Tutino, Nikola Yosifov, Amalia Milano, Luigia Florimonte, Elena Bonatto, Claudia Bareggi, Luca Dellavedova, Angelo Castello and 3 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Machine Learning Models Derived from [Bioengineering (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Andrea CiarmielloNuclear Medicine Department, Sant' Andrea Hospital, 19124 La Spezia, Italy.ORCID 0000-0002-6579-656X
Elisabetta GiovanniniNuclear Medicine Department, Sant' Andrea Hospital, 19124 La Spezia, Italy.ORCID 0009-0005-6567-5468
Francesca TutinoNuclear Medicine Department, Sant' Andrea Hospital, 19124 La Spezia, Italy.
Nikola YosifovNuclear Medicine Department, Sant' Andrea Hospital, 19124 La Spezia, Italy.
Amalia MilanoOncology Unit, Sant' Andrea Hospital, 19124 La Spezia, Italy.
Luigia FlorimonteNuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.ORCID 0000-0002-5254-6852
Elena BonattoDivision of Nuclear Medicine, IEO European Institute of Oncology IRCCS, 20122 Milan, Italy.
Claudia BareggiMedical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Luca DellavedovaNuclear Medicine Department, ASST Ovest Milanese, 20025 Legnano, Italy.
Angelo CastelloNuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Carlo AscheleOncology Unit, Sant' Andrea Hospital, 19124 La Spezia, Italy.ORCID 0000-0002-3317-5451
Massimo CastellaniNuclear Medicine Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.ORCID 0000-0002-9217-3456
Giampiero GiovacchiniNuclear Medicine Department, Sant' Andrea Hospital, 19124 La Spezia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FDGNSCLCPETradiomicssurvival

Identifiers

PMID38731142
PMCPMC11084602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.